JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 27 No. 7 1138-1142
© 1986 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shulkin, B. L.
Right arrow Articles by Beierwaltes, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shulkin, B. L.
Right arrow Articles by Beierwaltes, W. H.

Iodine-123-4-Amino-3-Iodobenzylguanidine, a New Sympathoadrenal Imaging Agent: Comparison with Iodine-123 Metaiodobenzylguanidine

Barry L. Shulkin, Brahm Shapiro, Michael C. Tobes, Shiao-Wei Shen, Donald M. Wieland, Laura J. Meyers, Helen T. Lee, Neil A. Petry, James C. Sisson and William H. Beierwaltes

Division of Nuclear Medicine, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan

Correspondence: For reprints contact: B. Shapiro, MB, ChB, PhD, Div. of Nuclear Medicine, Box 021, Dept. of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI 48109.

ABSTRACT

Iodine-123-4-amino-3-iodobenzylguanidine ([123I]AIBG), an analog of 123I metaiodobenzylguanidine ([123I]MIBG), has an advantage in having a more rapid and simple synthesis. This, combined with animal data that suggested a greater affinity of the new radiopharmaceutical for the autonomic innervation of the myocardium led us to study the biodistribution of [123I]AIBG in three men with metastatic pheochromocytoma. In all instances, [123I]AIBG revealed the same metastatic deposits shown by [123I]MIBG. Iodine-123 AIBG uptake, however, was greater than [123I]MIBG in lung, gut, and spleen. These higher backgrounds may pose diagnostic problems in some cases.




This article has been cited by other articles:


Home page
JNMHome page
M. A. Moroz, I. Serganova, P. Zanzonico, L. Ageyeva, T. Beresten, E. Dyomina, E. Burnazi, R. D. Finn, M. Doubrovin, and R. G. Blasberg
Imaging hNET Reporter Gene Expression with 124I-MIBG
J. Nucl. Med., May 1, 2007; 48(5): 827 - 836.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1986 by the Society of Nuclear Medicine.